Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Arterial Occlusive Diseases

2-amino-5-phosphonovalerate has been researched along with Arterial Occlusive Diseases in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kao, MC1
Lee, HK1
Chai, CY1
Wang, Y1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Arterial Occlusive Diseases

ArticleYear
NMDA antagonists attenuate hypertension induced by carotid clamping in the rostral ventrolateral medulla of rats.
    Brain research, 1991, May-17, Volume: 549, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Amino Acids; Animals; Anticonvulsants; Arterial Occl

1991